1. Background {#sec1}
=============

In the USA, since 2001 a resurgence in syphilis incidence, especially among males who have sex with men (MSM), has been observed \[[@B1]\]. By 2004, more than a half of new cases reported of primary and secondary syphilis were estimated to occur in MSM, with a high rate of HIV coinfection \[[@B2], [@B3]\]. During 2007-2008, the total number of cases of syphilis reported to the CDC increased 13.1% \[[@B4]\].

The increasing incidence of syphilis reported in many studies in the last decade, especially among MSM, is clearly a marker for higher risk behavior in this population and raises concerns for a parallel increase in HIV transmission \[[@B5]--[@B8]\].

It has been suggested that HIV infection modifies the clinical presentation of syphilis with greater organ involvement, atypical and florid skin rashes, and more rapid progression to neurosyphilis \[[@B9]--[@B12]\]; consequently, the diagnosis of syphilis in HIV-infected individuals represents a challenge for care providers. A careful sexual exposure history, recognition of clinical signs and symptoms, and interpretation of diagnostic testing are crucial in this context \[[@B13]\].

Detailed descriptions of oral manifestations of secondary syphilis in HIV-infected individuals are scarce in the scientific literature \[[@B14]--[@B19]\], in contrast with several reports in non-HIV-infected individuals \[[@B19]--[@B34]\]. Secondary syphilis may mimic other oral lesions such as nonspecific oral ulcerations, oral candidiasis, erythema multiforme, hairy leukoplakia, lichen planus, lupus erythematosus, erythroleukoplakia, and squamous cell carcinoma in both HIV and non-HIV-infected patients \[[@B14]--[@B34]\]. Moreover, because of the wide spectrum of oral clinical manifestations occurring in HIV-infected individuals, secondary syphilis in the mouth may be difficult to identify if not suspected by the clinician.

Considering that the incidence of syphilis is increasing in most countries, particularly in HIV-infected individuals \[[@B9]\] and that oral lesions may constitute the first or most florid clinical manifestation of the disease, the aim of the present case series is to describe the clinical spectrum of oral secondary syphilis in HIV-infected patients and its relevance in the early diagnosis of systemic syphilis.

2. Material and Methods {#sec2}
=======================

We report a series of 20 consecutive adult subjects with confirmed HIV infection who presented oral secondary syphilis lesions. Patients attended during the period from 2003 to 2011 two HIV/AIDS referral centers in Mexico City: the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMNSZ), a third level hospital, and the Clínica Especializada Condesa (CEC), a primary care center dedicated to the health care of HIV/AIDS patients who do not have social security. During the study period, between both institutions, approximately 2,000 active patients were seen.

Specialists in oral pathology and medicine, at the same AIDS clinic visit in both referral centers, consecutively evaluated all HIV-infected patients. During these visits, a structured oral examination was conducted by two of the authors (V. R.-Amador and G. A.-Saavedra). Syphilis-related oral lesions were classified according to previous criteria \[[@B35], [@B36]\] as follows. Macular lesions: flat-to-slightly raised, firm, red lesions with particular predilection of the hard palate.Papular lesions: red, raised, firm round nodules with a grey center that may ulcerate, usually located on the buccal mucosa or commissures.Mucous patches: slightly raised and covered by a grayish, white pseudomembrane, surrounded by erythema. Lesions appear mainly on the soft palate and pillars, tongue, and vestibular mucosa.Shallow ulcers: oval erosions or shallow ulcers of about one cm in diameter, covered by a grey mucoid exudate with an erythematous border.

In order to rule out other oral lesions, lesions suspected as oral syphilis were further evaluated with cytological smear. In macular and papular lesions, it was necessary to consider in the differential diagnosis oral candidosis (OC), particularly the erythematous type. Thus, a cytological smear was taken, and OC was excluded by the absence of *Candida* sp. in periodic acid Schiff (PAS) stained smears and/or the lack of an antifungal treatment response.

Likewise, in cases of shallow ulcerations located on keratinized oral mucosa, the diagnosis of intraepithelial human herpesvirus infection was ruled out by the absence of virus-infected cells in cytologic smears stained with Papanicolaou, and/or a lack of clinical response to systemic antiviral therapy with acyclovir.

A punch biopsy from oral lesions was performed in six patients who gave their consent to biopsy. For hematoxylin and eosin (H&E) stain, 5 *μ*m sections were cut from formalin-fixed and paraffin-embedded tissue samples. The silver nitrate-based staining method (Warthin-Starry) was used to identify spirochetes.

Immunohistochemistry was performed using a standard avidin-biotin peroxidase complex technique. Sections were stained with a primary polyclonal antibody against *Treponema pallidum*; antigen-binding sites were visualized through the peroxidase system (Biocare Medical, 4040 Pike Lane, Concord, CA 94520, USA, rabbit polyclonal CAT CP 135B).

In all patients diagnosis of syphilis was confirmed with a positive nontreponemal test at any titer (Venereal Disease Research Laboratory (VDRL) and if possible, a confirmatory fluorescent treponemal antibody test (FTA-ABS).

At diagnosis, medical records were reviewed for information about demographic and clinical characteristics which included risk behavior for HIV transmission, clinical stage \[[@B37]\], tobacco and alcohol use, CD4^+^ lymphocyte counts, plasma HIV-RNA level, and current antiretroviral therapy.

Description of variables was done using the Statistical Program for Social Sciences (SPSS) package, with a 95% confidence level. The prevalence of clinical and laboratory characteristics in patients was reported as percentages.

3. Results {#sec3}
==========

Twenty male adult patients, median age of 31.5 (range 21--59) years with oral secondary syphilis lesions, were identified during the study period, 10 at the AIDS Clinic of the INCMNSZ and 10 at the CEC. The clinical characteristics are shown in [Table 1](#tab1){ref-type="table"}; all patients were MSM, of whom 14 (70%) were receiving HAART, with a median time of use of 32.5 (1--134) months. Of the six patients without HAART, five were naive to antiretrovirals and one had discontinued HAART because of intolerance. The 20 cases were confirmed with positive serologic tests (VDRL in all, FTA-ABS in 15). It is important to mention that CEC is a free governmental HIV/AIDS clinic, so, because of financial issues, FTA-ABS was not performed in five patients; however, in three of them, besides a positive VDRL result, a biopsy led us to confirm the diagnosis. In the other two patients, in addition to a positive VDRL test, the clinical picture was characterized by oral mucous patches which is considered the most typical oral manifestation of secondary syphilis.

In 16 (80%) cases, oral lesions were either the first or most florid clinical sign that led to the diagnosis of secondary syphilis. In the remaining four patients (20%), oral manifestations were part of a systemic clinical picture already diagnosed as secondary syphilis by the treating clinician.

Eleven of the 20 patients (55%) had mucocutaneous involvement documented in the medical records. Skin manifestations included disseminated maculopapular rash (*n* = 5), hyper pigmented macules/erythematous plaques on palms and soles (*n* = 3), eyebrows/eyelashes alopecia (*n* = 2), and scalp alopecia (1).

The most common clinical manifestation of oral secondary syphilis was mucous patch in 17 cases (85.5%), the soft palate and pillars being the most frequent sites. Mucous patches appeared as white slightly raised plaques on an erythematous base with a serpentine and white/reddish well defined outline ([Figure 1](#fig1){ref-type="fig"}). Two patients presented shallow ulcers (10%), and, in one (5%), macular lesions were the most florid oral sign.

Ten (50%) of the 20 patients showed more than one type of syphilis-related oral lesion, concurrent mucous patches and papular lesions being the most frequent combination in four patients, followed by mucous patches and macular lesions in three, and shallow ulcers joint with mucous patches in two and with macular lesions in one ([Table 2](#tab2){ref-type="table"}).

We found four cases (20%) of papular syphilitic lesions in our population, all accompanied with mucous patches and located on dorsal tongue. Macular syphilitic lesions were identified on soft and hard palate (3), dorsum of tongue (1), and labial mucosa (1). In papular and macular cases, the clinical presentation of the oral lesions mimicked erythematous candidosis ([Figure 2(a)](#fig2){ref-type="fig"}); the absence of *Candida* sp. hyphae in the PAS smear, and the lack of response to topical or systemic antifungal treatment, allowed us to rule out erythematous candidosis.

One case of mucous patch on the lateral portion of the tongue resembled hairy leukoplakia ([Figure 2(b)](#fig2){ref-type="fig"}), and in another one, lesions in both sides of the tongue seemed lichen planus. In both cases a biopsy was taken and based in the histopathological features; the final diagnosis of oral syphilis was confirmed. In the patients who presented shallow ulcers on the palate (cases 1 and 13), the diagnosis of intraoral herpesvirus infection was ruled out as described in the Material and Methods section ([Figure 3](#fig3){ref-type="fig"}).

A biopsy of the oral lesions was taken in six patients who agreed with the procedure; biopsies were processed and stained with H&E and the silver nitrate-based staining method (Warthin-Starry). Microscopically, the lamina propria showed a diffuse (four out of six cases) and a perivascular (three out of six) lymphoplasmacytic inflammatory infiltrate. Occasional eosinophils and neutrophils were also present within the infiltrate and in the epithelium, forming microabscesses. In one case an interface lichenoid pattern was seen. The six oral biopsies examined showed psoriasiform and spongiotic changes in the epithelium; only in one of these cases, a pseudoepitheliomatous hyperplasia was present. Obliteration of the vessels was evident in all cases. Warthin-Starry stain detected spirochetes in the epithelium in two of the six biopsies. Immunohistochemistry for *T. pallidum* revealed numerous spirochetes within keratinocytes, free in the stroma of the lamina propria and within the vessel walls in examined biopsies ([Figure 4](#fig4){ref-type="fig"}).

4. Discussion {#sec4}
=============

In this paper we report twenty cases of oral secondary syphilis in HIV-infected patients evaluated in two AIDS referral centers in Mexico City, from 2003 to 2011. In most of these cases (80%) the oral lesions were the key clinical finding that led to the diagnosis of secondary syphilis; in the remaining cases, oral findings were additional clinical signs to a well-established clinical picture.

All cases in this series were males who have sex with men, as it has been stated by several authors in most countries, who have found in recent years an increase in syphilis among MSM \[[@B41]--[@B42]\]. In addition, almost half of our patients were young, less than 30 years (45%), in agreement with previous reports \[[@B38], [@B42]\].

In relation with CD4^+^ cell levels, it was found that only 7 (36.8%) of 19 patients had less than 350 cells/mm^3^ and 6 (30%) had a VL higher than 4 log~10~ copies/mL at the time of syphilis diagnosis. Different studies in HIV-infected patients with syphilis \[[@B10], [@B43]--[@B47]\] have reported a transient decrease in CD4^+^ cell count and an increase in VL.

It is important to highlight that during the study period no cases of oral primary or tertiary syphilis were observed. As it has been informed in HIV-infected patients \[[@B9], [@B11], [@B12]\], a higher rate of secondary syphilis is a common clinical finding; oral lesions are usually seen in secondary disease in patients with HIV \[[@B12]\].

Interestingly, even though the rate of HIV-syphilis coinfection has increased in the recent years \[[@B13]\], reports of oral manifestations of syphilis in HIV-infected patients are scarce \[[@B14]--[@B19], [@B48], [@B49]\]. In contrast, several reports have described oral lesions in non-HIV individuals \[[@B19]--[@B34]\].

Regardless of HIV status, the best recognized and characterized oral manifestation of secondary syphilis is the mucous patch, as shown in this case series in which 85.5% of the patients showed the typical slightly raised plaques, mainly located on the palate and soft pillars, which are the common sites described \[[@B35], [@B50]\].

Although the clinical criteria for mucous patches lesions usually involve slightly elevated plaques and superficial ulcers covered by a gray or white pseudomembrane (shallow ulcers) \[[@B36]\], we decided to consider shallow ulcers separately from mucous patches due to two main reasons: the frequent finding of isolated shallow ulcers in our population and the remarkable clinical differences between both types of lesions. Thus, a clinical description for shallow ulcers was added and defined independently from mucous patches as oval erosions or shallow ulcers of about 1 cm in diameter, covered by a grey mucous exudate with an erythematous border.

In addition to mucous patches \[[@B14], [@B17], [@B48]\], shallow ulcers \[[@B14], [@B17]\], papular \[[@B15], [@B16]\] and macular lesions \[[@B19]\] have also been described in HIV-infected patients with oral syphilis. As described by Ortega et al. \[[@B14], [@B17]\] we found four cases of shallow ulcers on palate, tongue, and labial mucosa. Also, as other authors have described \[[@B19], [@B36]\], palate was the favorite site for macular syphilis lesions that were found in five cases.

On the other hand, we found four (20%) papular cases, all accompanied with mucous patches and located on dorsal tongue, as it has been described by others \[[@B15], [@B16]\]. The term papular refers to red, raised, firm round nodules with a grey center that may ulcerate \[[@B36]\]; in this respect, we found that nodular lesions were covered by a depapillated surface, as described by Dalmau et al. \[[@B15]\] and Baniandrés-Rodríguez et al. \[[@B16]\].

The diagnosis of oral secondary syphilis lesions, called the great imitator \[[@B24], [@B51]\], represents an important clinical challenge. In our report, erythematous candidosis was considered as the differential diagnosis in nine of macular and papular cases, and herpes simplex infection in two patients with shallow ulcers.

Oral lesions mimicking hairy leukoplakia (HL) or lichen planus (LP) were also observed in one patient each. It is important to explain that in order to confirm the diagnosis of oral syphilis, besides the positive serology test, a biopsy and histopathological analysis were performed to rule out HL and LP. Hairy leukoplakia and leukoplakia-like plaque have been considered in the differential diagnosis of recent case reports of secondary syphilis in HIV seronegative patients \[[@B24], [@B28], [@B31]\]. Remarkably, secondary syphilis mimicking pemphigus vulgaris-like oral lesions has been illustrated in a recent case report \[[@B22]\].

The definitive diagnosis of syphilis is based on clinical data and complemented with serological and pathological studies. It is important to emphasize that all cases were confirmed with a positive serological test and when possible with histopathological analysis. Demonstration of tissue spirochetes using silver stain (Warthin-Starry) can be difficult, nonspecific, and time consuming, whereas immunohistochemical technique to detect *T. pallidum* in tissue sections has proven to be sensitive and specific and may be very useful in formalin-fixed paraffin wax embedded tissues \[[@B52], [@B53]\].

The present study has certain limitations that need to be taken into account when considering the diagnosis of oral secondary syphilis: first, not all patients gave their consent to the biopsy procedure, and second, there is a lack of confirmatory FTA-ABS tests in five patients of one of the referral centers. However, all five patients had positive VDRL tests, also three had confirmatory histopathological studies and two presented oral mucous patches, which are considered the most typical oral manifestations of secondary syphilis. Also, in doubtful cases a biopsy was done.

Although clinical features (particularly in cases of mucous patches) are highly suggestive of secondary syphilis, VDRL is a nonspecific blood test, so the definitive diagnosis must be confirmed by tissue sample and/or FTA-ABS test. However, it must be considered in agreement with some authors \[[@B12], [@B13], [@B54]\] that in secondary syphilis, VDRL is 100% sensitive and that the interpretation of treponemal and nontreponemal serological tests should be equivalent in HIV-infected and non-HIV-infected individuals. Also, in relation with sexual behavior only information about sex preference (MSM or heterosexual) was collected.

Our findings highlight that common oral diseases such as oral candidosis, intraoral human herpes virus infection, hairy leukoplakia, lichen planus, and other conditions considered by others such as lupus erythematosus, erythema multiforme, leukoplakia, erythroleukoplakia, squamous cell carcinoma, and nonspecific erosions should be included in the differential diagnosis of syphilis \[[@B14], [@B15], [@B17], [@B19], [@B24], [@B25], [@B27], [@B31]\].

5. Conclusions {#sec5}
==============

Oral manifestations are frequent and protean in HIV-infected patients; lesions caused by syphilis may be easily mistaken for other common entities in these patients, so it is important to emphasize the role of a thorough oral examination in its early diagnosis.

Since syphilis is a treatable disease with a significant potential for serious complications if not treated, a missed diagnosis can have serious consequences for the patient. In routine care, especially in developing countries, accurate diagnostic tools are not always available, so physicians should be conscious that oral lesions could be the only evident clinical manifestation of a common but complex disease like syphilis.

Clinicians should be aware of the variable manifestations of the disease and the need to suspect it in the presence of oral lesions. Based on the present case series, dental and medical practitioners should consider secondary syphilis in the differential diagnosis of white, ulcerative, popular, and nodular oral lesions, particularly in HIV-infected patients.
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![*Oral secondary syphilis.* White slightly raised plaques with a serpentine and white/reddish well-defined outline, located on hard, soft palate, pillars (a--c), and gingiva (d).](JSTD2013-892427.001){#fig1}

![*Oral secondary syphilis.* Papular lesions on the dorsum of the tongue mimicking erythematous candidosis (a), mucous patches, hairy leukoplakia-like, on the lateral side of the tongue (b).](JSTD2013-892427.002){#fig2}

![*Oral secondary syphilis.* Shallow ulcers on the hard palate mimicking intraoral herpes virus infection.](JSTD2013-892427.003){#fig3}

![*Secondary syphilis.* H&E stain (4x) shows a psoriasiform and lichenoid lymphoplasmacytic estomatitis with neutrophilic microabscesses in the stratum corneum (a), Warthin Starry stain (10x) shows a spirochete within the epithelium (dark small arrow) (b), and *Treponema pallidum* antibody (20x) shows multiple spirochetes within the epithelium (c).](JSTD2013-892427.004){#fig4}

###### 

Clinical characteristics in 20 patients with oral syphilis.

  ---------------------------------------------------------------------------
  Characteristics                                             *n* (% )
  ----------------------------------------------------------- ---------------
  AIDS^a^                                                     10 (50.0)

  On HAART                                                    14 (70.0)

  Tobacco consumption (*n* = 19)                              6 (31.6)

  Alcohol consumption (*n* = 19)                              4 (21.1)

  Main type of lesion                                          

   Mucous patches                                             17 (85.5)

   Shallow ulcers                                             2 (10.0)

   Macular lesions                                            1 (5.0)

  Oral site of main lesion^b^                                  

   Soft palate-pillars                                        8 (40.0)

   Hard palate                                                3 (15.0)

   Tongue                                                     3 (15.0)

   Hard-soft palate-pillars                                   2 (10.0)

   Hard-soft palate-tongue                                    1 (5.0)

   Hard-soft palate-tongue-buccal mucosa                      1 (5.0)

   Upper labial mucosa                                        1 (5.0)

   Gingiva                                                    1 (5.0)

  Minor type of lesion (*n* = 10)                              

   Papular lesions                                            4 (40.0)

   Macular lesions                                            4 (40.0)

   Shallow ulcers                                             2 (20.0)

  Oral site of minor lesion (*n* = 10)                         

   Tongue                                                     5 (50.0)

   Hard palate                                                3 (30.0)

   Gingiva/labial mucosa                                      1 (10.0)

   Soft palate                                                1 (10.0)

  Median antiretroviral use (range) months\                   32.5 (1--134)
  (*n* = 14)                                                  

  With undetectable viral load (\<399 copies/mL) (*n* = 19)   10 (52.6)

  Current median CD4^+^ count (range) cells/*μ*L (*n* = 19)   372 (44--734)
  ---------------------------------------------------------------------------

^a^ CD4^+^ T-lymphocyte count of \<200 cells/*μ*L (or \<14 percentage) and/or documentation of an AIDS-defining condition (A3, B3, C1--3) \[[@B37]\]. ^b^Main oral lesion was the most evident and florid oral manifestation.

###### 

Clinical characteristics of 20 patients with oral secondary syphilis.

  ------------------------------------------------------------------------------------------------------------------------------------
  ID   Clinical stage^a^   Current VL\   Current CD4^+^ \   Oral lesion       Site                           VDRL dilution   FTA-ABS
                           (copies/mL)   (cel/*μ*L)                                                                          
  ---- ------------------- ------------- ------------------ ----------------- ------------------------------ --------------- ---------
  1    B2                  6,310         378                Shallow ulcer\    Hard palate\                   1 : 16          ++++
                                                            Macular lesion    Gingiva, labial mucosa                         

  2    C3                  UND           202                Mucous patches    Hard palate                    1 : 8           ++

  3    C1                  NA            NA                 Mucous patches    Soft palate-pillars            1 : 32          ++++

  4    C3                  5,470         217                Mucous patches\   Soft palate-pillars\           1 : 256         +++
                                                            Papular lesion    Dorsal tongue                                  

  5    A3                  56,500        168                Mucous patches    Soft palate-pillars            1 : 128         +++

  6    A2                  100,000       239                Mucous patches\   Soft palate-pillars\           1 : 128         +++
                                                            Papular lesion    Dorsal tongue                                  

  7    A1                  9,656         681                Shallow ulcers    Upper labial mucosa            1 : 32          NA

  8    B3                  UND           458                Mucous patches    Soft palate-pillars            1 : 512         +++

  9    C3                  239,146       44                 Macular lesion    Dorsal lingual                 1 : 2           +++

  10   C3                  UND           372                Mucous patches\   Soft palate-pillars\           1 : 128         +++
                                                            Shallow ulcers    Tongue                                         

  11   A1                  47,011        603                Mucous patches\   Hard palate\                   1 : 2           \+
                                                            Macular lesion    Hard palate                                    

  12   A1                  13,259        648                Mucous patches\   Hard-soft palate-pillars\      1 : 4           \+
                                                            Papular lesion    Tongue                                         

  13   C2                  UND           715                Mucous patches\   Gingiva\                       1 : 64          +++
                                                            Shallow ulcers    Hard palate                                    

  14   C2                  UND           360                Mucous patches    Hard-soft palate-tongue        1 : 32          NA

  15   C3                  UND           187                Mucous patches\   Soft palate-pillars\           1 : 128         +++
                                                            Papular lesion    Dorsal tongue                                  

  16   C3                  UND           348                Mucous patches\   Soft palate-pillars, tongue\   1 : 32          NA
                                                            Macular lesion    Hard palate                                    

  17   B3                  UND           370                Mucous patches    Lateral sides of tongue        1 : 32          NA

  18   C3                  UND           392                Mucous patches    Soft palate-pillars            1 : 32          NA

  19   A1                  UND           734                Mucous patches    Hard-soft palate-pillars       1 : 64          +++

  20   A1                  205,000       532                Mucous patches\   Lateral tongue\                1 : 64          ++
                                                            Macular lesion    Soft palate                                    
  ------------------------------------------------------------------------------------------------------------------------------------

ID: identification, ^a^according to the CDC revised surveillance case definitions \[[@B37]\], VL: viral load, VDRL: venereal disease research laboratory, FTA-ABS: fluorescent treponemal antibody absorbed, UND: undetectable, NA: not available.

[^1]: Academic Editor: Bluma G. Brenner
